Heart Genomics, LLC is a biotechnology company focused on the development and the commercialization of non-invasive, genomic-based, clinical diagnostic tests for patients with heart disease or heart failure. The new diagnostic tests to be offered by Heart Genomics will provide personalized and individualized information to each patient and their physician through the genomic analysis of the patient's heart tissue or blood sample, and with this information, the heart patient and physician can make substantially improved and clear treatment decisions. With these diagnostic tests, Heart Genomics will be at the forefront of the burgeoning molecular diagnostics market.